Last reviewed · How we verify
AND017 capsules
At a glance
| Generic name | AND017 capsules |
|---|---|
| Sponsor | Kind Pharmaceuticals LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia (PHASE3)
- A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) (PHASE3)
- A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy (PHASE2)
- A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia (PHASE2)
- A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome (PHASE2)
- A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy (PHASE2)
- A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis (PHASE2)
- A Food-Effect Study of AND017 in Healthy Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |